Literature DB >> 29456797

Using tert-Butyl Groups in a Ligand To Identify Its Binding Site on a Protein.

Wan-Na Chen1,2, Gottfried Otting1.   

Abstract

Few methods allow determining the binding site of tightly binding ligands. We show that ligands containing a tert-butyl (e.g., Boc) group produce easily observable nuclear Overhauser effects (NOE) with the target protein even when the tert-butyl group is not highly solvent exposed. NOEs with methyl groups of the target protein are readily assigned by selectively isotope labeling, presenting a practical and quick way to pinpoint the location of the ligand without any prior specific nuclear magnetic resonance assignments of the protein. The approach works for nonexchanging ligands as well as for weakly binding ligands.

Entities:  

Year:  2018        PMID: 29456797      PMCID: PMC5807864          DOI: 10.1021/acsmedchemlett.7b00464

Source DB:  PubMed          Journal:  ACS Med Chem Lett        ISSN: 1948-5875            Impact factor:   4.345


  17 in total

1.  A macrocyclic HCV NS3/4A protease inhibitor interacts with protease and helicase residues in the complex with its full-length target.

Authors:  Nikolaus Schiering; Allan D'Arcy; Frederic Villard; Oliver Simic; Marion Kamke; Gaby Monnet; Ulrich Hassiepen; Dmitri I Svergun; Ruth Pulfer; Jörg Eder; Prakash Raman; Ursula Bodendorf
Journal:  Proc Natl Acad Sci U S A       Date:  2011-12-12       Impact factor: 11.205

2.  NMR in drug design.

Authors:  Mary J Harner; Luciano Mueller; Kevin J Robbins; Michael D Reily
Journal:  Arch Biochem Biophys       Date:  2017-06-13       Impact factor: 4.013

3.  Sensitive NMR Approach for Determining the Binding Mode of Tightly Binding Ligand Molecules to Protein Targets.

Authors:  Wan-Na Chen; Christoph Nitsche; Kala Bharath Pilla; Bim Graham; Thomas Huber; Christian D Klein; Gottfried Otting
Journal:  J Am Chem Soc       Date:  2016-03-24       Impact factor: 15.419

Review 4.  Twenty years on: the impact of fragments on drug discovery.

Authors:  Daniel A Erlanson; Stephen W Fesik; Roderick E Hubbard; Wolfgang Jahnke; Harren Jhoti
Journal:  Nat Rev Drug Discov       Date:  2016-07-15       Impact factor: 84.694

5.  A central region in the hepatitis C virus NS4A protein allows formation of an active NS3-NS4A serine proteinase complex in vivo and in vitro.

Authors:  C Lin; J A Thomson; C M Rice
Journal:  J Virol       Date:  1995-07       Impact factor: 5.103

6.  Discovery and early clinical evaluation of BMS-605339, a potent and orally efficacious tripeptidic acylsulfonamide NS3 protease inhibitor for the treatment of hepatitis C virus infection.

Authors:  Paul M Scola; Alan Xiangdong Wang; Andrew C Good; Li-Qiang Sun; Keith D Combrink; Jeffrey A Campbell; Jie Chen; Yong Tu; Ny Sin; Brian L Venables; Sing-Yuen Sit; Yan Chen; Anthony Cocuzza; Donna M Bilder; Stanley D'Andrea; Barbara Zheng; Piyasena Hewawasam; Min Ding; Jan Thuring; Jianqing Li; Dennis Hernandez; Fei Yu; Paul Falk; Guangzhi Zhai; Amy K Sheaffer; Chaoqun Chen; Min S Lee; Diana Barry; Jay O Knipe; Wenying Li; Yong-Hae Han; Susan Jenkins; Christoph Gesenberg; Qi Gao; Michael W Sinz; Kenneth S Santone; Tatyana Zvyaga; Ramkumar Rajamani; Herbert E Klei; Richard J Colonno; Dennis M Grasela; Eric Hughes; Caly Chien; Stephen Adams; Paul C Levesque; Danshi Li; Jialong Zhu; Nicholas A Meanwell; Fiona McPhee
Journal:  J Med Chem       Date:  2014-02-20       Impact factor: 7.446

7.  Preclinical Profile and Characterization of the Hepatitis C Virus NS3 Protease Inhibitor Asunaprevir (BMS-650032).

Authors:  Fiona McPhee; Amy K Sheaffer; Jacques Friborg; Dennis Hernandez; Paul Falk; Guangzhi Zhai; Steven Levine; Susan Chaniewski; Fei Yu; Diana Barry; Chaoqun Chen; Min S Lee; Kathy Mosure; Li-Qiang Sun; Michael Sinz; Nicholas A Meanwell; Richard J Colonno; Jay Knipe; Paul Scola
Journal:  Antimicrob Agents Chemother       Date:  2012-08-06       Impact factor: 5.191

8.  Chemical Tagging with tert-Butyl and Trimethylsilyl Groups for Measuring Intermolecular Nuclear Overhauser Effects in a Large Protein-Ligand Complex.

Authors:  Shereen Jabar; Luke A Adams; Yao Wang; Luigi Aurelio; Bim Graham; Gottfried Otting
Journal:  Chemistry       Date:  2017-08-18       Impact factor: 5.236

9.  All-oral daclatasvir plus asunaprevir for hepatitis C virus genotype 1b: a multinational, phase 3, multicohort study.

Authors:  Michael Manns; Stanislas Pol; Ira M Jacobson; Patrick Marcellin; Stuart C Gordon; Cheng-Yuan Peng; Ting-Tsung Chang; Gregory T Everson; Jeong Heo; Guido Gerken; Boris Yoffe; William J Towner; Marc Bourliere; Sophie Metivier; Chi-Jen Chu; William Sievert; Jean-Pierre Bronowicki; Dominique Thabut; Youn-Jae Lee; Jia-Horng Kao; Fiona McPhee; Justin Kopit; Patricia Mendez; Misti Linaberry; Eric Hughes; Stephanie Noviello
Journal:  Lancet       Date:  2014-07-28       Impact factor: 79.321

10.  Discovery of an allosteric mechanism for the regulation of HCV NS3 protein function.

Authors:  Susanne M Saalau-Bethell; Andrew J Woodhead; Gianni Chessari; Maria G Carr; Joseph Coyle; Brent Graham; Steven D Hiscock; Christopher W Murray; Puja Pathuri; Sharna J Rich; Caroline J Richardson; Pamela A Williams; Harren Jhoti
Journal:  Nat Chem Biol       Date:  2012-09-30       Impact factor: 15.040

View more
  1 in total

Review 1.  A Practical Perspective on the Roles of Solution NMR Spectroscopy in Drug Discovery.

Authors:  Qingxin Li; CongBao Kang
Journal:  Molecules       Date:  2020-06-28       Impact factor: 4.411

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.